Skip to main content
Signal8

Thornton Bruce

SEC insider (Form 3/4/5 filer). CIK 0001383288. Executive VP & COO at Sonoma Pharmaceuticals, Inc. (SNOA). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 19, 2025. Located in BOULDER, CO.

Companies Thornton Bruce has filed insider reports for

  • Sonoma Pharmaceuticals, Inc. (SNOA): Officer, Executive VP & COO
Thornton Bruce profile photo

Thornton Bruce

CIK: 0001383288

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sonoma Pharmaceuticals, Inc. logo
SNOA

Sonoma Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Sonoma Pharmaceuticals, Inc. logo
    SNOA

    Sonoma Pharmaceuticals, Inc.

    Jun 19, 2025
    Award

    Restricted Stock Units

    Direct
    13.5K shares-
  • Sonoma Pharmaceuticals, Inc. logo
    SNOA

    Sonoma Pharmaceuticals, Inc.

    Jan 2, 2025
    Award

    Restricted Stock Units

    Direct
    10K shares-

1-2 of 2